Thirteen patients with liver disease and an abnormal prothrombin time refractory to vitamin K therapy were studied (Tables 1 and 2). None of the patients were actively bleeding, and none had received ...
Recently, another modified one-stage method, developed by Owren, 7 has been given the distinctive name of thrombotest. Claims have been made that this test is more satisfactory for controlling ...
Do patients with renal disease have inherent coagulopathy? What prothrombin time (PT)/partial thromboplastin time (PTT) values can be expected with end-stage renal disease (ESRD)? —OMEL FIGUEROA, PA-C ...
The prothrombin gene mutation increases your risk of severe blood clots. Medications, regular checkups, and healthy lifestyle habits can help reduce this risk. The prothrombin gene plays a crucial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback